Building a Practical TB Laboratory Risk Matrix
A tuberculosis laboratory risk matrix turns scattered concerns into a visible, prioritised quality improvement plan. It helps a team identify where errors, contamination, delays, injuries or unreliable results could occur, then decide which risks need immediate controls and which can be monitored through routine quality activities.
For laboratories in Australia, the matrix can support a quality management system aligned with ISO 15189 and NATA expectations while remaining useful in everyday work. It should reflect the complete testing pathway, from specimen collection and transport to microscopy, culture, molecular testing, reporting, waste disposal and continual improvement.
Start With The Laboratory Workflow
The most reliable matrix begins with a process map rather than a generic list of hazards. Divide the TB pathway into pre-examination, examination and post-examination stages. Include ordering, patient identification, collection, packaging, transport, accessioning, preparation, testing, result authorisation, referral testing, storage and disposal.
A laboratory serving metropolitan hospitals in Melbourne or Sydney may receive specimens through several courier routes and referral networks. A smaller service in regional Queensland, Western Australia or the Northern Territory may face longer transport times, fewer trained staff and limited access to specialist maintenance. These differences change the likelihood and consequences of particular risks, so copying a matrix from another site can produce misleading priorities.
Ask staff to describe what actually happens during a busy shift. A routine morning handover, an urgent phone call from a clinician or a late courier arrival can reveal vulnerabilities that are absent from written procedures. Include normal work, unusual workloads, equipment outages, power interruptions, staff shortages and after-hours arrangements.
Useful risk events might include a rejected specimen, incorrect patient identification, delayed transport, aerosol generation, carryover between samples, an instrument result released without review or a failure to notify an urgent finding. Write each event clearly, using the format: “Because of this cause, this event could occur, leading to this consequence.”
Define Causes, Consequences And Existing Controls
A strong entry separates the risk from its cause and impact. For example, “incomplete decontamination of a work area” is a cause or control failure; “cross-contamination produces a false-positive molecular result” is the risk event and consequence. This distinction makes corrective action much more precise.
Record existing controls beside each risk. Controls may include validated procedures, sealed rotors, biological safety cabinets, unidirectional workflow, competency assessment, equipment maintenance, environmental monitoring, internal quality controls, result authorisation and incident reporting. A control should be specific enough to verify. “Staff are careful” is not a dependable control; “a second person checks specimen identifiers before testing” is.
The GLI Quality Tool can help organise this work through its four-phase roadmap and twelve Quality Systems Essentials. Map risks to relevant areas such as laboratory safety, personnel, equipment, purchasing and inventory, process control, information management, documents and records, assessment and continual improvement. This prevents the matrix becoming a separate spreadsheet that no one connects with the laboratory’s quality system.
Consider legal and accreditation duties in the Australian setting. Work health and safety obligations are established through state and territory legislation, so the matrix should reflect the requirements applying to the laboratory’s location. NATA assessment against ISO 15189 will also make evidence important: staff training records, maintenance logs, incident investigations, quality control results and documented review of risks should be easy to retrieve.
Score Risks Consistently
Choose simple scoring criteria and define them before the team rates individual risks. A common approach scores likelihood from 1 to 5 and consequence from 1 to 5, then multiplies the values. Consequences should cover patient care, public health, staff safety, result integrity, regulatory compliance, service continuity and reputation.
Likelihood should be based on evidence where possible: incident reports, nonconformities, rejected specimens, audit findings, quality indicators, near misses and staff observations. If the laboratory has no local data, use a cautious estimate and mark the uncertainty. A rare event with catastrophic consequences may need stronger controls than its numerical score suggests.
Rating Factors
- Likelihood: frequency, exposure and opportunities for failure
- Consequence: patient, public health, staff and service impact
- Detectability: chance the error will be found before a result is released
- Control strength: reliability, verification and documented ownership
A risk matrix should never allow a low likelihood score to hide a severe biosafety or diagnostic consequence. Add a rule that automatically escalates risks involving potential exposure to viable TB, release of an incorrect result, loss of a critical specimen or failure of a legally required report. Consider using a separate “critical risk” flag alongside the numerical rating.
Priority Actions
- Immediate containment for active safety or result-integrity threats
- Corrective action with an owner, due date and evidence requirement
- Routine monitoring for controlled but significant risks
- Acceptance and periodic review for low-level risks
When scoring, involve people who understand different parts of the workflow. A biomedical scientist may identify contamination pathways, a specimen reception officer may understand labelling failures, and a courier coordinator may know where transport assumptions break down. Record the reasons behind unusual scores rather than keeping only the final number.
Link Controls To The Testing Environment
TB molecular workflows deserve particular attention because small quantities of nucleic acid can create serious interpretation problems. Separate clean preparation, reagent handling, specimen processing and amplification areas where feasible. Control movement of staff, equipment and materials, and define how spills, failed runs and suspected contamination are investigated.
The matrix should identify risks involving unsuitable room layout, shared consumables, contaminated PPE, incorrectly placed controls, aerosol-generating steps and unclear cleaning responsibilities. Practical measures described in cross-contamination controls can be converted into specific control statements, verification activities and training requirements.
Equipment and supply risks also need local detail. Australian laboratories may depend on manufacturer service contracts, imported cartridges or reagents, and procurement arrangements shared across a health network. A delayed shipment through a national distributor, a back-ordered extraction kit or a service engineer travelling from another city can interrupt testing. Include minimum stock levels, approved alternatives, expiry checks, temperature monitoring and escalation contacts.
For rural and remote services, the risk matrix should address specimen stability and transport time rather than assuming same-day delivery. Define when a specimen must be recollected, when testing should be referred to a larger centre, and how results are communicated if internet, courier or laboratory information system access is disrupted. These controls make the matrix useful beyond the main laboratory bench.
Test Assumptions With Staff And Evidence
Risk assessment is more accurate when staff can challenge management assumptions without fear of blame. Hold a short facilitated session by workflow area, then compare comments with incidents, audits, quality indicators and customer complaints. Staff who work late shifts or in specimen reception should be included, because they often experience conditions that are invisible during office hours.
An anonymous improvement channel can help surface concerns about workload, unclear instructions or impractical controls. The guidance on staff feedback forms can support a structured method for gathering those observations and linking them to matrix entries. Review submissions for themes, assign an owner and communicate what action was taken.
Use evidence to challenge both overrating and underrating. A frequently recorded minor issue may have a lower consequence but deserve immediate process improvement because it is persistent. Conversely, a dramatic hypothetical event may already be well controlled. Confirm that controls work by observing practice, reviewing records, checking environmental or internal quality data and speaking with the people expected to apply them.
Document the basis for each high or extreme rating. Include the date assessed, participants, evidence reviewed, current controls, residual rating and approval. A matrix should show the risk after controls, not only the inherent risk before controls. This distinction helps leaders decide whether additional resources are justified.
Review The Matrix As A Living Record
Assign every significant risk to a named role rather than a committee or department. The owner does not need to complete every action personally, but must track progress, confirm effectiveness and escalate overdue work. Set review dates according to risk: critical items may require weekly or monthly monitoring, while stable low-level risks may be reviewed during a scheduled quality meeting.
Link matrix actions to existing systems, including corrective and preventive action, internal audits, management review, competency assessment, equipment records and supplier evaluation. A new analyser, change in extraction method, laboratory relocation, staffing change or serious incident should trigger an early review rather than waiting for the annual cycle.
A mock assessment can test whether the matrix is supported by evidence. The process described in mock accreditation survey can help staff check whether procedures, records and observed practice match the controls recorded in the risk register. Treat gaps as opportunities to strengthen the system, not simply as paperwork failures.
Track a small set of indicators, such as rejected specimens, contamination events, invalid runs, turnaround time, overdue maintenance, competency completion and corrective actions closed on time. Look for trends rather than isolated figures. When an indicator worsens, update the likelihood score, investigate the cause and confirm whether the selected control remains suitable.
Create the first matrix during a focused workshop, then improve it through use. Downloadable checklists and phase-specific materials from the GLI Quality Tool can help a laboratory move from identifying hazards to implementing, assessing and sustaining practical controls. Start with the highest-risk parts of the TB pathway, assign accountable owners and review the evidence at the next quality meeting.